Skip to main content
. 2023 Jun 6;14:90. doi: 10.1007/s12672-023-00678-3

Table 4.

Adverse events of the patient subgroup

Control group Experimental group
Grade 2 Grade 3 Grade 4 Grade 5 Grade 2 Grade 3
Laboratory abnormalities
Anemia 1 1 None none None None
Increased ALT/AST 2 None None none None None
Clinical adverse events
Abdominal pain 1 None None None None None
Cardiac arrest None None None 1 None None
Cerebral infarction None None 1 None None None
Constipation 2 None None None None None
Diarrhea 1 None None None 3 None
Dyspepsia 1 None None None None None
Fatigue 5 None None None None None
Headache None None None None 1 None
Hypertension 1 1 None None 2 None
Lethargy 1 None None None None None

ALT Alanine aminotransferase; AST Aspartate aminotransferase